Let’s look at the key reasons that are pushing BioAge Labs Inc (BIOA) to new highs

On Monday, BioAge Labs Inc (NASDAQ: BIOA) was -3.67% drop from the session before settling in for the closing price of $4.36. A 52-week range for BIOA has been $2.88 – $26.62.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

When this article was written, the company’s average yearly earnings per share was at 70.81%. With a float of $21.05 million, this company’s outstanding shares have now reached $35.85 million.

Let’s determine the extent of company efficiency that accounts for 64 employees. In terms of profitability, gross margin is 0.0%, operating margin of -5639.35%, and the pretax margin is -4896.28%.

BioAge Labs Inc (BIOA) Breakdown of a Key Holders of the stock

Also, it is sometimes useful to examine the sentiment of large-scale investors toward BioAge Labs Inc stocks. The insider ownership of BioAge Labs Inc is 41.29%, while institutional ownership is 32.33%. The most recent insider transaction that took place on Sep 27 ’24, was worth 47,376. In this transaction Principal Accounting Officer of this company bought 2,632 shares at a rate of $18.00, taking the stock ownership to the 2,632 shares. Before that another transaction happened on Oct 01 ’24, when Company’s Director bought 126,793 for $19.73, making the entire transaction worth $2,501,626. This insider now owns 1,026,793 shares in total.

BioAge Labs Inc (BIOA) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around 70.81% per share during the next fiscal year.

BioAge Labs Inc (NASDAQ: BIOA) Trading Performance Indicators

You can see what BioAge Labs Inc (BIOA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 13.68. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 103.84.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.03, a number that is poised to hit -0.48 in the next quarter and is forecasted to reach -2.26 in one year’s time.

Technical Analysis of BioAge Labs Inc (BIOA)

Looking closely at BioAge Labs Inc (NASDAQ: BIOA), its last 5-days average volume was 0.61 million, which is a jump from its year-to-date volume of 0.29 million. As of the previous 9 days, the stock’s Stochastic %D was 25.60%.

During the past 100 days, BioAge Labs Inc’s (BIOA) raw stochastic average was set at 68.75%, which indicates a significant increase from 10.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 37.18% in the past 14 days, which was lower than the 52.99% volatility it showed in the past 100 days.

However, in the short run, BioAge Labs Inc’s stock first resistance to watch stands at $4.35. Second resistance stands at $4.49. The third major resistance level sits at $4.59. If the price goes on to break the first support level at $4.11, it is likely to go to the next support level at $4.01. Now, if the price goes above the second support level, the third support stands at $3.87.

BioAge Labs Inc (NASDAQ: BIOA) Key Stats

There are 35,850K outstanding shares of the company, which has a market capitalization of 150.57 million. As of now, sales total 0 K while income totals -71,110 K. Its latest quarter income was 1,450 K while its last quarter net income were -12,930 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.